Leazer Rianna, Perkins Amy M, Shomaker Kyrie, Fine Bryan
Department of Pediatrics, Children's Hospital of the King's Daughters and Eastern Virginia Medical School, Norfolk, Virginia
Department of Pediatrics, Children's Hospital of the King's Daughters and Eastern Virginia Medical School, Norfolk, Virginia.
Hosp Pediatr. 2016 Apr;6(4):187-95. doi: 10.1542/hpeds.2015-0187. Epub 2016 Jan 1.
A change in the epidemiology of pathogens causing serious bacterial infection (SBI) has been noted since original recommendations were made for the empirical antibiotic choices for young infants with fever.
To assess the prevalence of SBI caused by Listeria monocytogenes and Enterococcus species.
A literature search was conducted on keywords related to SBI, L. monocytogenes, and Enterococcus spp. infections.
Eligible studies were those conducted in the United States and published between January 1998 and June 2014 focusing on SBI in infants≤90 days of age.
The rates of urinary tract infection, bacteremia, and meningitis for each pathogen were recorded for each study. Meta-analysis was performed to calculate the prevalence for each pathogen in a random effects model with 0.5 continuity correction added to studies with zero events.
Sixteen studies were included. A total of 20,703 blood cultures were included, with weighted prevalences for L. monocytogenes and Enterococcus spp. bacteremia of 0.03% and 0.09%, respectively. A total of 13,775 cerebrospinal fluid cultures were included with event rates (unweighted prevalences) for L. monocytogenes and Enterococcus spp. meningitis of 0.02% and 0.03%, respectively. A total of 18,283 urine cultures were included, with no cases of L. monocytogenes and a weighted prevalence for Enterococcus spp. urinary tract infection of 0.28%.
There may have been reporting bias or incomplete retrieval or inadvertent exclusion of relevant studies.
SBI caused by L. monocytogenes and Enterococcus spp. in febrile infants is rare, and therefore clinicians may consider a change in empirical antibiotic choices.
自最初针对发热的小婴儿经验性抗生素选择提出建议以来,已注意到引起严重细菌感染(SBI)的病原体流行病学发生了变化。
评估由单核细胞增生李斯特菌和肠球菌属引起的SBI的患病率。
对与SBI、单核细胞增生李斯特菌和肠球菌属感染相关的关键词进行了文献检索。
符合条件的研究是在美国进行的,发表于1998年1月至2014年6月之间,重点关注≤90日龄婴儿的SBI。
记录每项研究中每种病原体的尿路感染、菌血症和脑膜炎发生率。进行荟萃分析以计算随机效应模型中每种病原体的患病率,并对零事件的研究添加0.5连续性校正。
纳入了16项研究。共纳入20,703份血培养,单核细胞增生李斯特菌和肠球菌属菌血症的加权患病率分别为0.03%和0.09%。共纳入13,775份脑脊液培养,单核细胞增生李斯特菌和肠球菌属脑膜炎的事件发生率(未加权患病率)分别为0.02%和0.03%。共纳入18,283份尿培养,未发现单核细胞增生李斯特菌病例,肠球菌属尿路感染的加权患病率为0.28%。
可能存在报告偏倚、检索不完整或无意中排除相关研究的情况。
发热婴儿中由单核细胞增生李斯特菌和肠球菌属引起的SBI很少见,因此临床医生可能需要考虑改变经验性抗生素的选择。